On December 9, 2025, significant insider activity at Ligand Pharmaceuticals (NASDAQ:LGND) was disclosed as Jason Aryeh, a director at the company, exercised stock options for a...
On December 9, 2025, significant insider activity was reported at Ligand Pharmaceuticals (NASDAQ:LGND) as Jason Aryeh, a Director at the company, exercised stock options for a...